Pure red blood cell aplasia associated with chlorpropamide therapy. Patient summary and review of the literature.
D000293:Adolescent; D000328:Adult; D000636:Aminosalicylic Acids / Q000009:adverse effects; D000741:Anemia, Aplastic / Q000139:chemically induced*; D001241:Aspirin / Q000009:adverse effects; D001463:Barbiturates / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000009:adverse effects; D002747:Chlorpropamide / Q000009:adverse effects*; D003078:Colchicine / Q000009:adverse effects; D005260:Female; D005984:Glutethimide / Q000009:adverse effects; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D007223:Infant; D007538:Isoniazid / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D010672:Phenytoin / Q000009:adverse effects; D012256:Riboflavin / Q000627:therapeutic use
D000636:Aminosalicylic Acids; D001463:Barbiturates; D010672:Phenytoin; D002701:Chloramphenicol; D006493:Heparin; D005984:Glutethimide; D001241:Aspirin; D003078:Colchicine; D012256:Riboflavin; D007538:Isoniazid; D002747:Chlorpropamide